DexCom
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $1,209,300 | $1,157,100 | $1,036,000 | $1,113,500 |
Gross Profit | 731,400 | 688,800 | 589,000 | 655,800 |
EBITDA | 420,600 | 308,800 | 219,000 | 274,000 |
EBIT | 357,000 | 245,800 | 159,000 | 216,200 |
Net Income | 283,800 | 179,800 | 105,400 | 151,700 |
Net Change In Cash | 1,209,300 | 1,157,100 | 1,036,000 | 1,113,500 |
Free Cash Flow | 579,400 | 208,900 | 96,800 | 176,800 |
Cash | 1,835,700 | 1,159,000 | 904,900 | 606,100 |
Basic Shares | 407,400 | 408,200 | 407,500 | 406,700 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $4,033,000 | $3,622,300 | $2,909,800 | $2,448,500 |
Gross Profit | 2,438,200 | 2,288,900 | 1,883,100 | 1,680,500 |
EBITDA | 945,700 | 916,700 | 565,300 | 377,500 |
EBIT | 728,000 | 730,700 | 409,400 | 275,600 |
Net Income | 576,200 | 541,500 | 341,200 | 216,900 |
Net Change In Cash | 4,033,000 | 3,622,300 | 2,909,800 | 2,448,500 |
Cost of Revenue | -404,500 | 236,800 | ||
Free Cash Flow | 630,700 | 511,900 | 304,700 | 53,300 |
Cash | 606,100 | 566,300 | 642,300 | 1,052,600 |
Basic Shares | 412,700 | 425,500 | 427,500 | 428,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.61 |
2025-06-30 | $0.48 |
2025-03-31 | $0.32 |
